DCGI extends shelf life of Covishield vaccine from six to nine months
India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.31-03-2021
DCGI extends shelf life of Covishield vaccine from six to nine months
India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.Germany to discuss AstraZeneca Covid-19 shots after blood clot reports
Health Minister Jens Spahn will talk with his regional counterparts at 1800 CET (1600 GMT), a ministry spokesman saidIndia tells overseas vaccine buyers it has to prioritise local needs
Reports that India will delay deliveries of AstraZeneca's COVID-19 vaccine to a global programme to inoculate poorer countries triggered alarm on Thursday, with the head of Africa's disease control agency describing the continent as helpless.AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dated March 2, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018AstraZeneca updates Covid-19 vaccine efficacy rate to 76%
AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trialAstraZeneca Covid-19 vaccine 76% effective in new analysis of US trial
AstraZeneca said its Covid-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major US trial - a tad lower than tReputation of AstraZeneca's Covid-19 vaccine marred by missteps
AstraZeneca's release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it.How reputation of AstraZeneca's coronavirus vaccine is marred by missteps
AstraZeneca's encouraging data about its vaccine from US trial raised hopes that the drug company could bury doubts about the shotTaiwan kicks off vaccination drive with AstraZeneca's shot against Covid
Health care workers received the first shots in Taiwan's Covid-19 vaccination drive, beginning a campaign that won't use supplies from China amid uneven distribution of the vaccines globallyAstraZeneca counters Indonesian Muslim concerns over COVID-19 vaccine
Indonesia's highest Muslim clerical council, the Indonesia Ulema Council, said on its website Friday that the vaccine is "haram" because the manufacturing process uses "trypsin from the pork pancreas."